None listed
Conditions
Interventions
Dietary Supplement : • HydroCumin group: 1 tube once, single-dose, with water(300 mL){8g, 400 mg for curcuma longa L. extract(curcumin)}
• Curcumin group:1 tube once, single-dose, with water(300 mL){8
Sponsors
Wonkwang University Oriental Medical Hospital, Jeonju
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) healthy male aged 19 years-39 years at the screening test 2) BMI 17.5-29.9 kg/m^2 and weight 55 kg or more 3) Spontaneously agreed to participate in the study by the patients and legal guardians or parents
Exclusion criteria
Exclusion criteria: 1) Participants with a clinically significant disease requiring treatment (i.e., acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.) 2) Participants with a history of antipsychotic medication use within 3 months prior to the screening examination 3) Those who have or are suspected of alcohol or drug abuse 4) Those who participated in other human tirals within 2 months before the screening test 5) Patients who have laboratory test outcomes as follow ? AST(Aspartate aminotransferase), ALT(Alanine Transaminase) > three times the normal limit ? Serum Creatinine > 1.5 mg/dL 6) Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| density of curcumin | — |
Secondary
| Measure | Time frame |
|---|---|
| AUC, Cmax, Tmax, RB | — |
Countries
Korea, Republic of
Contacts
Public ContactJoo Jongcheon
Wonkwang University Oriental Medical Hospital, Jeonju
Outcome results
None listed